Teknova, Pluristyx complete FDA Type II DMF for PluriFreeze cryopreservation system

• Pluristyx is completing a Type II FDA Drug Master File for the PluriFreeze cryopreservation system used in cell-therapy manufacturing.
• Alpha Teknova is the exclusive manufacturer and distributor of PluriFreeze in the US and Canada.
• The filing is intended to support drugmakers that want to cross-reference the DMF in IND and BLA submissions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Teknova Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021601PRIMZONEFULLFEED9838903) on October 02, 2026, and is solely responsible for the information contained therein.